MRC1 and cancer: The high fraction of germline variants in MMR genes not detected by tumor-only sequencing that our analysis revealed could also be clinically detrimental to cancer patients’ families given that the family members would be unaware of their risk for Lynch syndrome and would not be screened under well-established Lynch syndrome protocols.26